News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BioAlliance Pharma Announces that Therabel launches Loramyc® in Germany With the Support of Hikma Pharmaceuticals



5/16/2011 12:11:03 PM

PARIS--(BUSINESS WIRE)--Regulatory News:BioAlliance Pharma SA (Euronext Paris: BIO), a company dedicated to specialty and orphan pharma products in oncology and supportive care, today announced that Loramyc® has been launched in Germany by its European partner Therabel. Therabel has created a fully dedicated team and has also entered into a co-promotion agreement with Hikma Pharma GmbH, a leading specialty pharmaceutical group focused on branded and generic products in Oncology.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES